Mereo Biopharma Group Stock News

In the last trading session, 1.33 million Mereo BioPharma Group plc (NASDAQ:MREO) shares changed hands as the companys beta touched 0. With the companys per share price at $1.60 changed hands at -$0.07 or -4.19% during last session, the market valuation stood at $180.80M. MREOs last price was a discount, traded about -194.38% off its Could Mereo BioPharma Group plc (NASDAQ: MREO) Post Life-Changing Returns? Read More »

The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative development. The sector r

Mereo BioPharma Group plc (NASDAQ:MREO) concluded the trading at $1.67 on Thursday, December 02 with a fall of -0.60% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $1.68 and 5Y monthly beta was reading 1.49 with its price kept floating in Mereo BioPharma Group plc (MREO) Should Be Considered Now, Despite A Loss Of -64.55% From High Read More »

One complete response, one partial response and four cases of stable disease observed among 15 patients in the efficacy analysis set

The stock price of Mereo BioPharma (NASDAQ: MREO) increased by over 1.5% pre-market today. This is why it happened.

Mereo BioPharma Group plc (NASDAQ:MREO) price on Wednesday, November 17, fall -4.21% below its previous days close as a downside momentum from buyers pushed the stocks value to $2.05. A look at the stocks price movement, the close in the last trading session was $2.14, moving within a range at $1.8301 and $2.10. The beta Mereo BioPharma Group plc (NASDAQ: MREO) Is Expected To Rise To 10.00 USD! Read More »

LONDON and REDWOOD CITY, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO), “Mereo” or “the Company”, a clinical-stage biopharmaceutical company focused on on

LONDON and REDWOOD City, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on o

The shares of Mereo BioPharma Group plc (NASDAQ: MREO) have received a price target of $10 by Needham. These are the details.

Mereo BioPharma is a biopharma company focused on oncology and rare diseases, suiting a market cap of $388M USD at the time of this article. The company currently has great partnerships in place, whic

LONDON and REDWOOD CITY, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on on

LONDON and REDWOOD CITY, Calif., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on on

LONDON and REDWOOD CITY, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on on

Looking for penny stocks to buy? Click for seven that are hot right now and should continue to rise in the future.